Award

Maquat celebrated for her service
and scientific achievements

She won the FASEB Excellence in Science Award
Amber Lucas
By Amber Lucas
April 01, 2018

Lynne E. Maquat, the J. Lowell Orbison endowed chair and director of the Center for RNA Biology at the University of Rochester Medical Center, is the recipient of the 2018 Federation of American Societies for Experimental BiologyExcellence in Science Award. Maquat is being recognized for her outstanding contributions to our understanding of RNA biology and her enthusiastic service to the scientific community.


 

“It is an honor to receive the FASEB Excellence in Science Award. I look forward to meeting many Experimental Biology 2018 participants, especially those just starting their careers. Even after establishing my own lab, I wasn’t sure that I would be a successful scientist. A career in science can have many unpredictable twists and turns. However, if you chip away in a steady and thoughtful way, you may be surprised at what you can accomplish.”

— LYNNE E. MAQUAT

FASEB established the Excellence in Science Award in 1989 to celebrate outstanding women in science who have made landmark scientific discoveries, shown leadership and a devotion to service in the broader scientific community, and shown dedication to the training of students and postdoctoral fellows.

Jeffrey J. Hayes, chair and Shohei Koide professor in the department of biochemistry and biophysics at the University of Rochester Medical Center, nominated Maquat for the award. “Lynne is a highly esteemed scientist who is a leader in mammalian gene expression and has contributed numerous seminal discoveries elucidating fundamental aspects of mRNA regulation,” Hayes wrote in his letter of nomination. “Lynne’s innovative work, her unparalleled contributions to science, her record of unselfish service to the scientific community and her efforts fostering future scientists’ careers, clearly indicate that she is an outstanding choice for the FASEB Excellence in Science Award.”

Maquat’s research on RNA decay pathways focuses on nonsense-mediated mRNA decay, or NMD, and how disruption of this pathway can lead to disease in humans. The NMD pathway targets mRNAs with premature stop codons for degradation, protecting against the potentially deleterious effects caused by expression of the truncated proteins encoded by these mRNAs. Maquat’s discovery and understanding of the NMD mechanism has been instrumental in the fundamental understanding of RNA biology, how disruption of RNA regulation can lead to diseases and how manipulation of this pathway could be used to treat those diseases.

Maquat also has been an outstanding role model for the scientific community outside the lab. In 2003, she established the University of Rochester Graduate Women in Science program to offer mentorship for women scientists and provide them with opportunities for professional and personal development. As president of the RNA Society, she also initiated networking and mentoring, and she is a constant advocate for diversity in the sciences.

Maquat earned her Ph.D. from the University of Wisconsin-Madison and decided to stay there for her postdoctoral work at the McArdle Laboratory for Cancer Research. Since joining the University of Rochester, she has published more than 135 papers in peer-reviewed journals and has been recognized with numerous awards including the Canada Gairdner International Award, the Vanderbilt Prize in Biomedical Science, an NIH MERIT Award, the International RNA Society Lifetime Achievement in Service Award, the International RNA Society Lifetime Achievement in Science Award and the Wiley Prize in Biomedical Sciences. She also has been elected to societies such as the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Association for the Advancement of Science.

Maquat will receive her award during the Experimental Biology 2018 meeting in San Diego, where she will deliver an award lecture titled “Nonsense-mediated mRNA decay and human disease: genome guardian and executor.” The presentation will take place at 9 a.m. April 22 in Room 6B in the San Diego Convention Center.

Amber Lucas
Amber Lucas

Amber Lucas is a graduate student in the department of biological sciences at Carnegie Mellon University.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in People

People highlights or most popular articles

'Every experiment and every breakthrough matters'
Health Observance

'Every experiment and every breakthrough matters'

February 26, 2021

An interview with NYMC dean Marina K. Holz, who studies a rare disease that affects women of childbearing age.

Connecting chemistry with education
Jobs

Connecting chemistry with education

February 26, 2021

Meet Christiane Stachl, director of education, outreach and diversity at Center for Genetically Encoded Materials at UC Berkeley.

Raising awareness and funding for Pompe disease
Health Observance

Raising awareness and funding for Pompe disease

February 25, 2021

Father-turned-advocate has founded multiple organizations to support families and search for better therapies for people with rare lysosomal storage disorder.

Tributes to Barbara Gordon, ASBMB executive director, on her retirement
Stroopwafels

Tributes to Barbara Gordon, ASBMB executive director, on her retirement

February 24, 2021

Society members and former staff share their appreciation and memories of Gordon who worked at the American Society for Biochemistry and Molecular Biology for almost 50 years.

Booker edits new journal; Bumpus featured in virtual museum
Member News

Booker edits new journal; Bumpus featured in virtual museum

February 22, 2021

Awards, promotions, milestones and more. Find out what's going on in the lives of ASBMB members.

Remembering Kanfer and Barry
In Memoriam

Remembering Kanfer and Barry

February 22, 2021

Julian Kanfer was one of the first researchers to study the link between amyloid ß protein and Alzheimer’s disease. Bridgette Barry focused on how the dynamic protein matrix facilitates enzyme-based catalysis.